This targeted uptake in diseased tissue is a genuinely unusual pharmacological property that makes KPV particularly well-suited to inflammation-driven gut conditions like ulcerative colitis and IBD
515 , 735 , 736 In 2019, the National Institute on Aging (NIA) awarded funding to create the NIA Imbedded Pragmatic AD/ADRD Clinical Trials (IMPACT) Collaboratory
10.1016/j.carbpol.2024.122637 99 WangH.ChenY.WeiR.ZhangJ.ZhuJ.WangW.et al (2024f)
In addition, compared to selective PPAR agonists, targeting two isotypes or pan-PPAR agonists combines the beneficial effects of selective PPAR agonists and improves NAFL/NASH more effectively in multiple ways
To be used as a dietary supplement in a normal food program. Certified free of: Starch, corn, milk, wheat, yeast, sugar, eggs, salt, artificial colors, binders, flavors, preservatives and fish derivatives
Zhang S, Chai FY, Guo Y, Harding JJ